These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 11730261

  • 1. Therapy of male osteoporosis with parathyroid hormone.
    Bilezikian JP, Kurland ES.
    Calcif Tissue Int; 2001 Oct; 69(4):248-51. PubMed ID: 11730261
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Parathyroid hormone versus bisphosphonate treatment on bone mineral density in osteoporosis therapy: a meta-analysis of randomized controlled trials.
    Shen L, Xie X, Su Y, Luo C, Zhang C, Zeng B.
    PLoS One; 2011 Oct; 6(10):e26267. PubMed ID: 22022584
    [Abstract] [Full Text] [Related]

  • 6. Parathyroid Hormone Plus Alendronate in Osteoporosis: A Meta-Analysis of Randomized Controlled Trials.
    Wang C, Zhang G, Gu M, Fan J, Chen J, Zhang G, Li B.
    J Invest Surg; 2015 Oct; 28(6):309-16. PubMed ID: 26270229
    [Abstract] [Full Text] [Related]

  • 7. A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis.
    Hodsman AB, Fraher LJ, Watson PH, Ostbye T, Stitt LW, Adachi JD, Taves DH, Drost D.
    J Clin Endocrinol Metab; 1997 Feb; 82(2):620-8. PubMed ID: 9024265
    [Abstract] [Full Text] [Related]

  • 8. Does bone resorption inhibition affect the anabolic response to parathyroid hormone?
    Martin TJ.
    Trends Endocrinol Metab; 2004 Mar; 15(2):49-50. PubMed ID: 15080150
    [Abstract] [Full Text] [Related]

  • 9. Intermittent parathyroid hormone therapy to increase bone formation.
    Thomas T.
    Joint Bone Spine; 2006 May; 73(3):262-9. PubMed ID: 16563840
    [Abstract] [Full Text] [Related]

  • 10. ALX 111: ALX1-11, parathyroid hormone (1-84) - NPS Allelix, PREOS, PTH, recombinant human parathyroid hormone, rhPTH (1-84).
    Adis International Ltd.
    Drugs R D; 2003 May; 4(4):231-5. PubMed ID: 12848587
    [Abstract] [Full Text] [Related]

  • 11. Parathyroid hormone added to established hormone therapy: effects on vertebral fracture and maintenance of bone mass after parathyroid hormone withdrawal.
    Cosman F, Nieves J, Woelfert L, Formica C, Gordon S, Shen V, Lindsay R.
    J Bone Miner Res; 2001 May; 16(5):925-31. PubMed ID: 11341338
    [Abstract] [Full Text] [Related]

  • 12. Enhancement of bone mass in osteoporotic women with parathyroid hormone followed by alendronate.
    Rittmaster RS, Bolognese M, Ettinger MP, Hanley DA, Hodsman AB, Kendler DL, Rosen CJ.
    J Clin Endocrinol Metab; 2000 Jun; 85(6):2129-34. PubMed ID: 10852440
    [Abstract] [Full Text] [Related]

  • 13. Parathyroid hormone and parathyroid hormone-related protein analogs as therapies for osteoporosis.
    Augustine M, Horwitz MJ.
    Curr Osteoporos Rep; 2013 Dec; 11(4):400-6. PubMed ID: 24078470
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The effects of parathyroid hormone, alendronate, or both in men with osteoporosis.
    Finkelstein JS, Hayes A, Hunzelman JL, Wyland JJ, Lee H, Neer RM.
    N Engl J Med; 2003 Sep 25; 349(13):1216-26. PubMed ID: 14500805
    [Abstract] [Full Text] [Related]

  • 16. Parathyroid hormone(1-84) treatment of postmenopausal women with low bone mass receiving hormone replacement therapy.
    Fogelman I, Fordham JN, Fraser WD, Spector TD, Christiansen C, Morris SA, Fox J.
    Calcif Tissue Int; 2008 Aug 25; 83(2):85-92. PubMed ID: 18626566
    [Abstract] [Full Text] [Related]

  • 17. The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis.
    Black DM, Greenspan SL, Ensrud KE, Palermo L, McGowan JA, Lang TF, Garnero P, Bouxsein ML, Bilezikian JP, Rosen CJ, PaTH Study Investigators.
    N Engl J Med; 2003 Sep 25; 349(13):1207-15. PubMed ID: 14500804
    [Abstract] [Full Text] [Related]

  • 18. [Parathyroid and bone. Role of parathyroid hormone in the treatment of osteoporosis].
    Nakamura T.
    Clin Calcium; 2007 Dec 25; 17(12):1823-9. PubMed ID: 18057656
    [Abstract] [Full Text] [Related]

  • 19. Parathyroid hormone--a drug for orthopedic surgery?
    Skripitz R, Aspenberg P.
    Acta Orthop Scand; 2004 Dec 25; 75(6):654-62. PubMed ID: 15762254
    [Abstract] [Full Text] [Related]

  • 20. Short-term, high-dose parathyroid hormone-related protein as a skeletal anabolic agent for the treatment of postmenopausal osteoporosis.
    Horwitz MJ, Tedesco MB, Gundberg C, Garcia-Ocana A, Stewart AF.
    J Clin Endocrinol Metab; 2003 Feb 25; 88(2):569-75. PubMed ID: 12574182
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.